Clinical trial
9-valent CRM 197 Pneumococcal
NCT00133549 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00133549 |
|---|---|
| Title | 9-valent CRM 197 Pneumococcal |
| Official title | Evaluation of a 9-valent CRM 197- Conjugated Pneumococcal Polysaccharide Vaccine in Elderly Adults |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pneumococcal Infection |
| Intervention type | Biological, Drug |
| Interventions | Placebo, PNU-IMUNE®23, Nine-valent pneumococcal conjugate (PNCRM9) |
| Enrollment | 180 |
| Start date | Nov 1, 2000 |
| Primary completion | Dec 1, 2002 |
| Completion | Dec 1, 2002 |
| First posted | Aug 23, 2005 |
| Last update posted | Oct 17, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: